Business Description
Jiangsu Recbio Technology Co Ltd
ISIN : CNE1000057K9
Share Class Description:
FRA:G93: Class HDescription
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.28 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.61 | |||||
| Debt-to-EBITDA | -1.32 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -52.1 | |||||
| 3-Year EPS without NRI Growth Rate | -41 | |||||
| 3-Year FCF Growth Rate | -48.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 75.78 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.77 | |||||
| 9-Day RSI | 31.38 | |||||
| 14-Day RSI | 36.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.54 | |||||
| Quick Ratio | 2.33 | |||||
| Cash Ratio | 1.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | -7.71 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -41.48 | |||||
| ROA % | -25.27 | |||||
| ROIC % | -52.93 | |||||
| 3-Year ROIIC % | -50.93 | |||||
| ROC (Joel Greenblatt) % | -60.76 | |||||
| ROCE % | -29.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.49 | |||||
| Price-to-Tangible-Book | 3.5 | |||||
| EV-to-EBIT | -5.94 | |||||
| EV-to-EBITDA | -6.72 | |||||
| EV-to-FCF | -4.12 | |||||
| Earnings Yield (Greenblatt) % | -16.83 | |||||
| FCF Yield % | -24.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangsu Recbio Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.153 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 36.57 | ||
| 14-Day ATR (€) | 0.035972 | ||
| 20-Day SMA (€) | 0.97915 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.81 - 1.0366 | ||
| Shares Outstanding (Mil) | 482.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangsu Recbio Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangsu Recbio Technology Co Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jiangsu Recbio Technology Co Ltd Frequently Asked Questions
What is Jiangsu Recbio Technology Co Ltd(FRA:G93)'s stock price today?
The current price of FRA:G93 is €0.91. The 52 week high of FRA:G93 is €1.04 and 52 week low is €0.81.
When is next earnings date of Jiangsu Recbio Technology Co Ltd(FRA:G93)?
The next earnings date of Jiangsu Recbio Technology Co Ltd(FRA:G93) is .
Does Jiangsu Recbio Technology Co Ltd(FRA:G93) pay dividends? If so, how much?
Jiangsu Recbio Technology Co Ltd(FRA:G93) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers